(Q50908445)

http://europepmc.org/abstract/MED/26606967

25 March 2018

title

Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. (English)

1 reference

http://europepmc.org/abstract/MED/26606967

25 March 2018

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Daniela S Thommen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Kea Martin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sai T Reddy

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Philipp Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Matthias Kreuzaler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Katharina Glatz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Spasenija Savic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Nadia Harbeck

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ulrike Nitz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Oleg Gluz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Michael von Bergwelt-Baildon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Hans Kreipe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Matthias Christgen

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alfred Zippelius

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

1 November 2015

1 reference

http://europepmc.org/abstract/MED/26606967

25 March 2018

published in

Science Translational Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

315ra188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

7 June 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-08-1776

Identifiers

DOI

10.1126/SCITRANSLMED.AAC4925

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26606967%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference